Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Judit Rejtö"'
Autor:
A. Simonne Paine, Seon Jai Choi, Wilma M. Hopman, Laura L. Swystun, David Lillicrap, Kenichi Ogiwara, Sylvia Kepa, Judit Rejtö, Ingrid Pabinger
Publikováno v:
Journal of Thrombosis and Haemostasis. 19:654-663
Background Factor VIII (FVIII) pharmacokinetics (PK) in adult hemophilia A populations are highly variable and have been previously determined to be influenced by von Willebrand factor:antigen (VWF:Ag), ABO blood group, and age. However, additional g
Autor:
Dino Mehic, Matthias Haimel, Stefanie Hofer, Helmuth Haslacher, Alexander Tolios, Cihan Ay, Johanna Gebhart, Judit Rejtö, Willem H. Ouwehand, Kate Downes, Ingrid Pabinger
Publikováno v:
Blood Adv
High levels of tissue factor pathway inhibitor (TFPI), caused by a longer TFPIα half-life after binding to a factor V splice variant and variants in the F5 gene, were recently identified in 2 families with an as-yet-unexplained bleeding tendency. Th
Publikováno v:
European Journal of Internal Medicine. 78:34-40
Background : Bleeding assessment tools (BATs) have been developed to quantify bleeding severity. Their ability to predict for the diagnosis of a bleeding disorder has not been thoroughly investigated. Objectives : To evaluate the ability of the Vicen
Autor:
Helmuth Haslacher, Stefanie Hofer, Alisa S. Wolberg, Johanna Gebhart, Ingrid Pabinger, Judit Rejtö, Cihan Ay, Silvia Koder
Publikováno v:
Journal of Thrombosis and Haemostasis
Background In a large proportion of patients with a mild to moderate bleeding tendency no diagnosis can be established (bleeding of unknown cause, BUC). Objectives To investigate possible dysfunctions in thrombin generation and plasma clot formation
Publikováno v:
Annals of Hematology
The current standard of care treatment for severe hemophilia A and B (SHA and SHB) is the prophylactic intravenous replacement of coagulation factor VIII or IX (FVIII/FIX) to prevent spontaneous bleeding. Persons with hemophilia without prophylactic
Autor:
Judit Rejtö, Christoph Male, Kerstin Plessl, Peter Putz, Meike Klinger, Christina Kaufmann, S. Durstberger, Ingrid Pabinger, Klaus Widhalm
Publikováno v:
Haemophilia
Introduction 3D gait analysis has been proposed as a reproducible and valid method to assess abnormal gait patterns and to monitor disease progression in patients with haemophilia (PWH). Aim This study aimed at comparing Gait Deviation Index (GDI) be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ffb8ccdc951425d96e7e3a2d022914
https://pub.fh-campuswien.ac.at/doi/10.1111/hae.14154
https://pub.fh-campuswien.ac.at/doi/10.1111/hae.14154